Global Cell Therapy Market Forecast 2022-2030

Global Cell Therapy Market Forecast 2022-2030

KEY FINDINGS

The global cell therapy market is projected to register a CAGR of 14.46% during the forecast period, 2022-2030. The market growth is accredited to the increasing prevalence of chronic disease, thriving regenerative medicine, and rising cellular therapy clinical trials.

MARKET INSIGHTS

Cell therapy has a vast range of applications in offering diagnostic/prognostic information during clinical research related to several infectious diseases, cancer, and HIV/AIDS. Also, several factors like the growing population, climate change, and the growing contact between animals and humans have raised the threat of virus outbreaks. Cell therapy replaces dysfunctional or diseased cells with healthy functioning ones. The cells majorly used for such advanced therapies are stem cells, given their ability to differentiate into specific cells needed for repairing defective cells.

Further, cell therapy has applications in the development of regenerative medicine. Additionally, cells like bone marrow and blood cells, embryonic stem cells, adult stem cells, and solid & immature cells are used in cell therapy procedures. Such factors drive the global cell therapy market growth. However, the growing skills gap restricts market growth.

REGIONAL INSIGHTS

The global cell therapy market’s geographical segmentation includes the assessment of Asia-Pacific, Europe, North America, and Rest of World. North America is the largest revenue-generating region in the global market, supplemented by the presence of key players, advanced healthcare infrastructure, robust reimbursement policies, extensive research and development, etc.

COMPETITIVE INSIGHTS

Some of the eminent companies operating in the market include Bristol Myers Squibb Company, Gilead Sciences Inc, Cells for Cells SA, JCR Pharmaceuticals Co Ltd, Anterogen Co Ltd, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments